CAMBRIDGE, Mass., April 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of high-performance specialty enzymes and next-generation cellulosic ethanol, today announced that following the successful commissioning of Verenium's demonstration-scale facility in Jennings, Louisiana, and the recent ann...
CAMBRIDGE, Mass., March 24, 2009 /PRNewswire-FirstCall via COMTEX/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of high-performance specialty enzymes and next-generation cellulosic ethanol, today announced it has signed an agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling...
CAMBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Carlos A. Riva, President and Chief Executive Officer, will present at the upcoming ThinkEquity ThinkGreen Conference. The presen...
CAMBRIDGE, Mass., March 16 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that its Form 10-K filed with the Securities and Exchange Commission (SEC) on March 16, 2009 included an audit opinion that contained ...
CAMBRIDGE, Mass., Feb. 23 /PRNewswire-FirstCall/ -- Verenium Corporation
(Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic
ethanol and high-performance specialty enzymes, reported financial results for
the fourth quarter and year-ended December 31, 2008. The Company also
provided a summary of recent highlights and a...
CAMBRIDGE, Mass., Feb 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- BP and Verenium Corporation (Nasdaq: VRNM) today announced the formation of a 50-50 joint venture to develop and commercialize cellulosic ethanol from non-food feedstocks. The joint venture company will act as the commercial entity for the deployment of cellulosic ethanol techno...
CAMBRIDGE, Mass., Feb. 16 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it will release 2008 fourth quarter and year-end financial results on Monday, February 23, 2009 after market close. In conju...
CAMBRIDGE, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced plans to build its first commercial-scale cellulosic ethanol facility in Highlands County, Florida. The Company has entered into long-t...
CAMBRIDGE, Mass., Jan. 13 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it has regained compliance with the continued listing requirements of The NASDAQ Global Market. NASDAQ previously notified Vereniu...
CAMBRIDGE, Mass., Jan. 13 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it has regained compliance with the continued listing requirements of The NASDAQ Global Market. NASDAQ previously notified Vereniu...
CAMBRIDGE, Mass., Dec. 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it received notice from The NASDAQ Stock Market that it is presently not in compliance with NASDAQ Marketplace Rule 4450(b)(1)(A), ...
CAMBRIDGE, Mass., Nov. 18 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes today announced the departure of John A. McCarthy, Jr. from the position of Chief Financial Officer effective immediately. Jeffrey G. Black, Vice Presid...
CAMBRIDGE, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Verenium Corporation
(Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic
ethanol and high-performance specialty enzymes, today reported financial
results for the third quarter of 2008 and provided recent Company highlights
and accomplishments.
"I am very p...
CAMBRIDGE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Carlos A. Riva, President and Chief Executive Officer, will speak at the upcoming Credit Suisse Alternative Energy Conference as pa...
CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it will release third quarter 2008 financial results on Monday, November 10, 2008 after market close. In conjunction with the relea...
CAMBRIDGE, Mass., Oct. 15 /PRNewswire-FirstCall/ -. Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Carlos A. Riva, President and Chief Executive Officer, will present at the upcoming Jefferies 6th Global Clean Technology Confere...
CAMBRIDGE, Mass., Oct. 7 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the appointment of Gregory Powers, Ph.D., to the position of Executive Vice President, Research and Development. Powers will report dire...
CAMBRIDGE, Mass., Sept. 30 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Janet Roemer, Executive Vice President and General Manager, Specialty Enzymes Business, will present at the upcoming William Bla...
CAMBRIDGE, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that John A. McCarthy, Jr., Executive Vice President and Chief Financial Officer, will present at the upcoming Citi 2008 Agriculture C...
CAMBRIDGE, Mass., Sept. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that members of its management team will be presenting at two upcoming conferences.
John A. McCarthy, Jr., Executive Vice Presi...
Delicious
Digg
Facebook
LinkedIn
Twitter
